https://www.selleckchem.com/products/3po.html
tion of drug may be required during edoxaban use for PVT, especially after hepatobiliary surgery. Although edoxaban is recently described to be one of the options for patients with PVT who require anticoagulation therapy instead of heparin or warfarin, it should be used with caution, given its propensity to induce severe hemorrhagic adverse events in cases such as those described above. The monitoring of hepatic dysfunction and decision for continuation of drug may be required during edoxaban use for PVT, especially after hepatobiliary surg
Like
Comment
Share
